Korean red pine needle (RPN) exhibits various biological and pharmacological activities. Among the various compounds of RPN, we isolated dehydroabietic and 4-epi-trans-communic acid. At first, we confirmed that two compounds inhibited angiotensin converting enzyme (ACE) and induced p-Akt in human umbilical vein endothelial cells (HUVEC). RPN extract powder significantly reduced systolic blood pressure in spontaneous hypertensive rats (SHRs) through the reduced expression of ACE and angiotensin type I receptors in the lungs of SHRs. The Lineweaver–Burk plots suggested that the two compounds were noncompetitive inhibitors of ACE. Using docking analysis, we found that two compounds showed the best returned pose at ACE active sites, and formed hydrogen and hydrophobic bonds with ACE residues. These results demonstrate that RPNs may be a source of compounds effective for preventing hypertension and may be useful in the development of antihypertensive drugs.
Get full access to this article
View all access options for this article.
References
1.
YoonSS, GuQ, NwankwoT, et al.: Trends in blood pressure among adults with hypertension United States, 2003 to 2012. Hypertension, 2015; 65:54–61.
2.
MozaffarianD, BenjaminEJ, GoAS, et al.: Heart disease and stroke statistics-2016 update: A report from the American heart association. Circulation, 2016; 133:447–454.
3.
SaleemR, AhmedM, AhmedSI, et al.: Hypotensive activity and toxicology of constituents from root bark of Polyalthia longifolia var. pendula. Phytother Res, 2005; 19:881–884.
4.
CampbellDJ, AlexiouT, XiaoHD, et al.: Effect of reduced angiotensin-converting enzyme gene expression and angiotensin-converting enzyme inhibition on angiotensin and bradykinin peptide levels in mice. Hypertension, 2004; 43:854–859.
5.
Gonzalez-VillaobosRA, BilletS, KimC, et al.: Intrarenal angiotensin-converting enzyme induces hypertension in response to angiotensin I infusion. J Am Soc Nephrol, 2011; 22:449–459.
6.
CrowleySD, GurleySB, HerreraMJ, et al.: Angiotensin II causes hypertension and cardiac hypertrophy through its receptor in the kidney. Proc Natl Acad Sci USA, 2006; 103:17985–17990.
7.
IaccarinoG, CiccarelliM, SorrientoD, et al.: AKT Participates in Endothelial Dysfunction in Hypertension. Circulation, 2004; 109:2587–2593.
8.
HammerschmidtS, KuhnH, GessnerC, et al.: Stretch-induced alveolar type II cell apoptosis: role of endogenous bradykinin and PI3K-Akt signaling. Am J Respir Cell Mol Biol, 2007:37:699–705.
9.
KimKY, ChungHJ: Flavor compounds of pine sprout tea and pine needle tea. J Agric Food Chem, 2000; 48:1269–1272.
10.
JungMJ, ChungHY, ChoiJH, ChoiJS: Antioxidant principles from the needles of red pine Pinus densiflora. Phyother Res, 2003; 17:1064–1068.
11.
ParkJ, LeeB, ChoiH, KimW, KimHJ, CheongH: Antithrombosis activity of protocatechuic and shikimic acids from functional plant Pinus densiflora Sieb. et Zucc needles. J Nat Med, 2016; 70:492–501.
12.
ParkG, PaudyalDP, HwangI, TripathiGR, YangY, CheongH: Production of fermented needle extracts from red pine and their functional characterization. Biotechnol Bioprocess Eng, 2008; 13:256–261.
13.
KhokhrinaEA, ShpatovAV, PopovSA, Sal′nikovaOI, ShmidtEN, et al.: Non-volatile compounds of needles, trimmed saplings, and outer bark of Pinus densiflora. Chem Nat Compd, 2013; 49:561–565.
14.
SultanMZ, JeonYM, MoonSS: Labdane-type diterpenes active against acne from pine cones (Pinus densiflora). Planta Med, 2008; 74:449–452.
15.
TapiaAA, VallejoMD, GouiricSC, FeresinGE, RossomandoPC, et al.: Hydroxylation of dehydroabietic acid by Fusarium species. Phytochemistry, 1997; 46:131–133.
16.
FallareroA, SkogmanM, KujalaJ, et al.: (+)-Dehydroabietic acid, an abietane-type diterpene, inhibits Staphylococcus aureus biofilms in vitro. Int J Mol Sci, 2013; 14:12054–12072.
17.
KinouchiY, OhtsuH, TokudaH, NishinoH, MatsunagaS, et al.: Potential antitumor-promoting diterpenoids from the stem bark of Picea g lehni. J Nat Prod, 2000; 63:817–820.
18.
TanakaR, TokudaH, EzakiY: Cancer chemopreventive activity of “rosin” constituents of Pinus spez. and their derivatives in two-stage mouse skin carcinogenesis test. Phytomedicine, 2008; 15:985–992.
19.
JangHJ, YangKS: Inhibition of nitric oxide production in RAW 264.7 macrophages by diterpenoide from Phellinus pini. Arch Pharmacal Res, 2011; 34:913–917.
20.
KangMS, HiraiS, GotoT, et al.: Dehydroabietic acid, a phytochemical, acts as ligand for PPARs in macrophages and adipocytes to regulate inflammation. Biochem Biophys Res Commun, 2008; 369:333–338.
21.
YangXW, FengL, LiSM, et al.: Isolation, structure, and bioactivities of abiesadines A-Y, 25 new diterpenes from Abies georgei Orr. Bioorg Med Chem, 2010; 18:744–754.
22.
KangMS, HiraiS, GotoT, et al.: Dehydroabietic acid, a diterpene, improves diabetes and hyperlipidemia in obese diabetic KK-Ay mice. Biofactors, 2009; 35:442–448.
23.
TakahashiN, YaoR, KangMS, et al.: Dehydroabietic acid activates peroxisome proliferator-activated receptor-γ and stimulates insulin-dependent glucose uptake into 3T3-L1 adipocytes. Biofactors, 2011; 37:309–314.
24.
HusseinAA, MeyerJJ, JimenoML, RodríguezB: Bioactive diterpenes from Orthosiphon labiatus and Salvia africana-lutea. J Nat Prod, 2007; 70:293–295.
DaughertyA, RateriD, HongL, BalakrishnanA: Measuring blood pressure in mice using volume pressure recording, a tail-cuff method. J Vis Exp, 2009; 15:1291.
30.
XieJ, ChenX, WuJ, et al.: Antihypertensive effects, molecular docking study, and isothermal titration calorimetry assay of angiotensin I-converting enzyme inhibitory peptides from Chlorella vulgaris. J Agric Food Chem, 2018; 66:1359–1368.
31.
NateshR, SchwagerSLU, SturrockED, AcharyaKR: Crystal structure of the human angiotensin-converting enzyme-lisinopril complex. Nature, 2003; 421:551–554.
DeLanoWL: Pymol: An open-source molecular graphics tool. Ccp4 Newsletter Protein Crystallogr, 2002; 40:11.
34.
CorradiHR, SchwagerSL, NchindaAT, SturrockED, AcharyaKR: Crystal structure of the N domain of human somatic angiotensin I-converting enzyme provides a structural basis for domain-specific inhibitor design. J Mol Biol, 2006; 357:964–974.
35.
CrowleySD, GurleySB, OliverioMI, et al.: Distinct roles for the kidney and systemic tissues in blood pressure regulation by the renin-angiotensin system. J Clin Invest, 2005; 115:1092–1099.
36.
HwangAY, DaveC, SmithSM: Trends in antihypertensive medication use among US patients with resistant hypertension, 2008 to 2014. Hypertension, 2016; 68:1349–1354.
37.
MakaniH, MesserliFH, RomeroJ, et al.: Meta-analysis of randomized trials of angioedema as an adverse event of renin-angiotensin system inhibitors. Am J Cardiol, 2012; 110:383–391.
38.
YusufS, TeoKK, PogueJ, et al.: Telmisartan, ramipril, or both in patients at high risk for vascular events. N Engl J Med, 2008; 358:1547–1559.
39.
AkifM, MasuyerG, SchwagerSLU, et al.: Structural characterization of angiotensin I-converting enzyme in complex with a selenium analogue of captopril. FEBS J, 2011; 278:3644–3650.
40.
GengX, TianG, ZhangW, et al.: A Tricholoma matsutake peptide with angiotensin converting enzyme inhibitory and antioxidative activities and antihypertensive effects in spontaneously hypertensive Rats. Sci Rep, 2016; 6:24130.
41.
ZhangC, WuS, XuD: Catalytic mechanism of angiotensin-converting enzyme and effects of the chloride ion. J Phys Chem, 2013; 117:6635–6645.
42.
ShannonRS, NihalM, AhmadN: Dose translation from animal to human studies revisited. FASEB J, 2007; 22:659–661.
43.
LahlouS, de Barros CorreiaCAJr, Vasconcelos Dos SantosM, et al.: Mechanisms underlying the cardiovascular effects of a labdenic diterpene isolated from Moldenhawera nutans in normotensive rats. Vasc Pharmacol, 2007; 46:60–66.
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
